P-012 | IMPLEMENTATION OF INFORMATION TECHNOLOGY GOVERNANCE FRAMEWORK FOR BLOOD SERVICES IN RESOURCE CONSTRAINED SETTING | Tonderai Mapako | Received |
P-022 | IMPROVING NEONATAL AND PAEDIATRIC CLINICAL OUTCOMES THROUGH PATIENT BLOOD MANAGEMENT EDUCATION | David Peterson | Received |
P-024 | INCONGRUENCE IN WHOLE BLOOD DONOR SELECTION CRITERIA AS EVALUATED BY EXPERTS IN THE TRANSPOSE PROJECT IN COMPARISON WITH DIRECTIVE 2004/33/EC | Stefano Fontana | Received |
P-031 | PARTNERSHIP TO ELIMINATE BLOOD WASTE: THE CARDIAC SURGERY BLOOD COOLER INITIATIVE | Kerry OBrien | Received |
P-033 | INTERACTIVE METRICS FOR MONITORING BLOOD SUPPLY MANAGEMENT SYSTEM IN A LOW RESOURCE SETTING | Tonderai Mapako | Received |
P-036 | IDENTIFYING COMPATIBLE BLOOD FOR RH ALLOIMMUNIZED PATIENTS: AN INTERNATIONAL CASE | Margaret Keller | Received |
P-071 | CHARACTERISTICS OF WHOLE BLOOD AND APHERESIS DONORS IN THE RUSSIAN FEDERATION | Alexander Chechetkin | Received |
P-074 | FINNISH BLOOD DONOR BIOBANK | Jukka Partanen | Received |
P-080 | FAMILIAL HYPERCHOLESTEROLAEMIA SCREENING IN A BLOOD DONATION PROGRAM | stephen Eason | Received |
P-082 | FERRIDON - A NATIONAL CROSS-SECTIONAL STUDY ASSESSING THE PREVALENCE OF IRON DEFICIENCY USING FERRITIN ASSAY AMONG WHOLE-BLOOD DONORS IN FRANCE | Anne-Marie Fillet | Received |
P-091 | ZERO IS THE BEST RESULT: VALIDATION OF THE SKIN DISINFECTION METHOD | Saila Vasama | Received |
P-097 | INSIGHTS IN SAFETY AND RETENTION RATES OF DONOR VS COLLECTION VOLUME; RESULTS FROM AN INTERNATIONAL SURVEY OF PLASMAPHERESIS PRACTICES | Johanna Castrén | Received |
P-099 | COMPARISON OF PERFORMANCES OF SOFTWARE TRIMA ACCEL VERSION 6.06 TO VERSION 7 | André Rapaille | Received |
P-107 | DO DONERS OVER 66 YEARS OF AGE HAVE MORE ADVERCE EVENTS COMPARED TO OTHER AGE GROUPS | Tarja Jrvinen | Received |
P-110 | PROTECTION AGAINST POLLEN ALLERGY AND ASTHMA IN BLOOD DONORS BY PRESEASONAL ORAL SUPPLEMENTATION WITH AN IMMUNOMODULATORY AGARICUS BLAZEI-BASED MUSHROOM EXTRACT: A RANDOMIZED PLACEBO-CONTROLLED STUDY | Geir Hetland | Received |
P-125 | THE STORAGE MODE OF SHEEP PLATELET CONCENTRATES DIFFERENTIALLY AFFECTS MICROPARTICLE FORMATION | Gabriela Simonova | Received |
P-127 | DUAL POOLING STRATEGY FOR PRODUCTION OF PLATELET CONCENTRATES FROM 5 OR 6 BUFFY COATS | Nicolas Cellier | Received |
P-155 | ASSESSMENT OF RED CELL CONCENTRATES PRODUCED FROM 7 DAYS -STORED LEUCODEPLETED WHOLE BLOOD | Stephane Begue | Received |
P-156 | IGE SENSITIZATION PROFILES TO FOOD, INHALANT AND INSECT VENOM ALLERGENS IN NORWEGIAN BLOOD DONORS MEASURED WITH LINE-BLOT MULTIPLEX ENZYMOIMMUNOASSAY | Lise Sofie H Nissen-Meyer | Received |
P-159 | USE OF NANOPARTICLE TRACKING ANALYSIS TO CHARACTERISE MICROVESICLES IN RED CELL UNITS: EFFECTS OF STORAGE ON MICROVESICLE SIZE AND CONCENTRATION | John-Paul Tung | Received |
P-160 | MANUAL METHOD FOR WASHING RED BLOOD CELLS USING SAGM SOLUTION | Juha Eronen | Received |
P-195 | EVALUATION OF AN ANTIOXIDANT POWER MEASURE TO VALIDATE THE PLATELET CONCENTRATES VIRO-INACTIVATED BY INTERCEPT TREATMENT | Anas Lotens | Received |
P-196 | EVALUATION OF AN ANTIOXIDANT POWER MEASURE TO VALIDATE THE PLASMA UNITS VIRO-INACTIVATED BY METHYLEN-BLUE TREATMENT | Anas Lotens | Received |
P-201 | BIOTINYLATED RED BLOOD CELLS: A PROMISING APPROACH FOR MONITORING IN VIVO RED BLOOD CELL SURVIVAL IN CLINICAL TRIALS | Catherine RAVANAT | Received |
P-203 | INJECTABLE BIOTINYLATED PLATELETS FOR TRANSFUSION IN CLINICAL TRIALS | Catherine RAVANAT | Received |
P-209 | DOMESTIC AND INTERNATIONAL COLLABORATION FOR THE SCREENING AND PROCUREMENT OF RARE RED BLOOD CELLS | Sandra Nance | Received |
P-232 | PERFORMANCE EVALUATION OF ELECSYS SEROLOGY ASSAYS IN A BLOOD ESTABLISHMENT | Marie-Pierre RODENBACH | Received |
P-240 | INDUCTION HEATING: AN ADVANCED WASHING TECHNOLOGY TO PRESERVE SAMPLE INTEGRITY ON ALINITY S, ALINITY I, AND ARCHITECT I2000SR FOR TRANSFER TO NUCLEIC ACID TESTING INSTRUMENTS | Matt Effinger | Received |
P-277 | HIV PREVALENCE AND INCIDENCE ESTIMATES AMONG BLOOD DONORS IN FIVE REGIONS IN CHINA | Ling Shi | Received |
P-281 | SEPTIC PLATELET TRANSFUSION REACTIONS DUE TO ACINETOBACTER BAUMANNII AND STAPHYLOCOCCUS SAPROPHYTICUS DESPITE NEGATIVE PRIMARY TESTING AND NEGATIVE POINT-OF-RELEASE TESTING | David Peaper | Received |
P-313 | DISCREPANT LITTLE C TYPING IN AN RH:-26 DONOR | Tanya Cawthorne | Received |
P-320 | SIGNIFICANCE OF THE MONOCYTE MONOLAYER ASSAY IN PREDICTING THE CLINICAL RELEVANCE OF ANTI-GERBICH ANTIBODIES | Sofia Lejon Crottet | Received |
P-322 | DIFFERENCES IN STABILITY OF UNEXPECTED RED BLOOD CELL ANTIBODIES DETECTED AFTER REFRIGERATION OR FREEZING USING AUTOMATED ANALYZER IH-500 AND MANUAL TUBE METHODS | Jeong Won Shin | Received |
P-348 | RARE JENU NEGATIVE DONOR IDENTIFIED THROUGH INCOMPATIBLE CROSSMATCH | Tanya Powley | Received |
P-357 | MOLECULAR BLOOD GROUP SCREENING IN DONORS FROM ARABIAN COUNTRIES USING HIGH-THROUGHPUT MALDI-TOF SPECTROMETRY AND PCR-SSP | Brigitte Flesch | Received |
P-368 | A NOVEL ABOA GENE SINGLE NUCLEOTIDE MUTATION LEADS TO DISCREPANT RESULTS IN FORWARD/REVERSE AND MOLECULAR BLOOD GROUPING | Jana Rosochova | Received |
P-372 | A NOVEL RHD SPLICE DONOR SITE MUTATION LEADING TO A RHD-NEGATIVE PHENOTYPE | Jolanda Stettler | Received |
P-373 | CHARACTERIZATION OF TWO NOVEL RHD VARIANT ALLELES | Jolanda Stettler | Received |
P-376 | THE RHD ALLELE INVENTORY: LESSONS FROM HIGH-THROUGHPUT GENOME DATABASES | Franz WAGNER | Received |
P-380 | RHD ALLELIC VARIANTS IN CAUCASIAN DONORS SEROLOGICALLY CLASSIFIED AS D-NEGATIVE | Tommaso Mancuso | Received |
P-408 | COMPARISON OF ABO GENOTYPING METHODS: A STUDY OF TWO LOW RESOLUTION PCR ASSAYS IN A CLINICAL TESTING LABORATORY | margaret keller | Received |
P-423 | A RARE CASE OF SEVERE REFRACTORY THROMBOCYTOPENIA IN A PATIENT WITH COMBINED HLA CLASS I, HPA-1A AND HPA-3A ANTIBODIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION | Brigitte Flesch | Received |
P-426 | HUMAN NEUTROPHIL ANTIGEN ALLELE FREQUENCIES AND ASSESSMENT OF HNA ALLOIMMUNIZATION RISK IN BLOOD DONORS AND RECIPIENTS | Irina Krobinets | Received |
P-443 | CASE REPORT ANTI INDIAN B ANTIBODY IN A PREGNANT WOMAN OF INDIAN ORIGIN | Ann Lea Vogel | Received |
P-445 | SEVERE CASE OF HAEMOLYTIC DISEASE OF FETUS AND NEWBORN OCCURRING IN BABY WHO HAS INHERITED A NOVEL RHD ALLELE ASSOCIATED WITH A PARTIAL RHD POSITIVE PHENOTYPE | Tanya Powley | Received |
P-465 | HIGH -GRADE PARASITEMIA IN BABESIOSIS TREATED WITHOUT ADJUNCTIVE RED CELL EXCHANGE | Joseph Sweeney | Received |
P-492 | DEVELOPMENT OF A TRANSFUSION-INDICATION DATA-ENTRY PROGRAM AND ANALYSIS OF TRANSFUSION INDICATIONS THROUGH THIS PROGRAM IN A TERTIARY CARE HOSPITAL IN KOREA | Jeong Won Shin | Received |
P-514 | DEVELOPMENT OF AN OVINE MODEL OF HAEMORRHAGIC SHOCK | John-Paul Tung | Received |
P-518 | CHARACTERIZATION OF IMMUNOMODULATORY MEDIATORS IN CONVENTIONAL AND CRYOPRESERVED SHEEP PLATELET CONCENTRATES | Gabriela Simonova | Received |
P-519 | CHARACTERIZATION OF IMMUNOMODULATORY MEDIATORS IN SHEEP PACKED RED BLOOD CELLS: DEVELOPMENT OF A ROBUST TRANSFUSION MODEL | Gabriela Simonova | Received |
P-523 | TOWARDS UNDERSTANDING OF POST-TRANSFUSION IMMUNOMODULATION: SHEEP IMMUNE RESPONSES TO LIPOPOLYSACCHARIDE | Gabriela Simonova | Received |
P-536 | HAEMOGLOBIN OPTIMISATION USING IV IRON | Josephine McCullagh | Received |
P-547 | CD34 CALCULATION TOOL; A SIMPLE AND EASY TOOL FOR PERSONALIZED STEM CELL COLLECTION | Betina Sorensen | Received |
P-548 | IMMUNOTHERAPY PRODUCTS: BLOOD PRODUCT, PHARMACEUTICAL, OR A NEW CATEGORY ALL TOGETHER? | Sarah Vossoughi | Received |
June 22-26, 2019 Basel
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|